​

Funding Round

Series D - AveXis

Series D - AveXis

Investment Firm

Overview

AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.

Announced Date

Sep 08, 2015

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

T. Rowe Price

T. Rowe Price

T. Rowe Price is a convertible_note and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

12

Investor Name
Participant InvestorDeerfield
Participant InvestorT. Rowe Price
Participant InvestorRoche Venture Fund
Participant InvestorVenrock
Participant InvestorQVT Financial

Round Details and Background

AveXis raised $65000000 on 2015-09-08 in Series D

AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 22, 2014
Series B - AveXis
-undefined
Jul 27, 2013
Series A - AveXis
-undefined
Sep 08, 2015
Series D - AveXis
12-65.0M
Jan 09, 2015
Series C - AveXis
2-10.0M

Recent Activity

There is no recent news or activity for this profile.